| 000 | 01727 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514191107.0 | ||
| 264 | 0 | _c20040916 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0300-7995 | ||
| 024 | 7 |
_a10.1185/030079904125003421 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAthyros, Vasilios G | |
| 245 | 0 | 0 |
_aEffect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cMay 2004 |
||
| 300 |
_a627-37 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGreece |
| 650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNational Health Programs |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMikhailidis, Dimitri P | |
| 700 | 1 | _aPapageorgiou, Athanasios A | |
| 700 | 1 | _aSymeonidis, Athanasios N | |
| 700 | 1 | _aMercouris, Bodosakis R | |
| 700 | 1 | _aPehlivanidis, Anthimos | |
| 700 | 1 | _aBouloukos, Vasilios I | |
| 700 | 1 | _aElisaf, Moses | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 20 _gno. 5 _gp. 627-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/030079904125003421 _zAvailable from publisher's website |
| 999 |
_c14879045 _d14879045 |
||